Keywords: COVID-19, ICU, Remdesivir, Solidarity, Trial, WHO.
[http://dx.doi.org/10.1093/jac/dkaa321] [PMID: 32829390]
[http://dx.doi.org/10.1056/NEJMoa2007764] [PMID: 32445440]
[http://dx.doi.org/10.1093/cid/ciaa1041] [PMID: 32706859]
[http://dx.doi.org/10.2147/DDDT.S261154]
New Emirates Medical Journal
Title:Dubious Results of Remdisivir Ultimately in Solidarity; Diversity of Severity of Illness is Doubtful
Volume: 2 Issue: 1
Author(s): Seyed Mohammad Reza Hashemian*, Hamidreza Jamaati, Mostafa Norizadehtazehkand, Majid Malkmohammad, Parisa Adimi and Ali Amirsavadkouhi
Affiliation:
- Iranian Society of Critical Care, Critical Care, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Keywords: COVID-19, ICU, Remdesivir, Solidarity, Trial, WHO.
Export Options
About this article
Cite this article as:
Hashemian Reza Seyed Mohammad*, Jamaati Hamidreza, Norizadehtazehkand Mostafa, Malkmohammad Majid, Adimi Parisa and Amirsavadkouhi Ali, Dubious Results of Remdisivir Ultimately in Solidarity; Diversity of Severity of Illness is Doubtful, New Emirates Medical Journal 2021; 2 (1) . https://dx.doi.org/10.2174/0250688201999201120113151
DOI https://dx.doi.org/10.2174/0250688201999201120113151 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Post-translational Modifications of bZIP Transcription Factors in Abscisic Acid Signaling and Drought Responses
Current Genomics Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs
Current Drug Metabolism Lipid Nanoparticles for the Delivery of Biopharmaceuticals
Current Pharmaceutical Biotechnology Fc-independent Phagocytosis: Implications for IVIG and other Therapies in Immune-mediated Thrombocytopenia
Cardiovascular & Hematological Disorders-Drug Targets Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus
Letters in Drug Design & Discovery Sirolimus Eluting Stent: A New Era in Interventional Cardiology?
Current Pharmaceutical Design Inducible Nitric Oxide Synthase as a Possible Target in Hypertension
Current Drug Targets Protective Effect of Schizolobium parahyba Flavonoids Against Snake Venoms and Isolated Toxins
Current Topics in Medicinal Chemistry Viral Elements Sense Tumorigenic Processes:Approaching Selective Cancer Therapy
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 2
Current Immunology Reviews (Discontinued) Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Current Gene Therapy Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry Endothelial Dysfunction in Sepsis
Current Vascular Pharmacology Role of Microglia in the Pathogenesis of Sepsis-Associated Encephalopathy
CNS & Neurological Disorders - Drug Targets Mechanisms of Plant Defense Under Pathogen Stress: A Review
Current Protein & Peptide Science Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options
Current Diabetes Reviews Editorial [Welcome to our Recent Patents on Biotechnology Special Edition on Skeletal Muscle Diseases!]
Recent Patents on Biotechnology Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014
Current Drug Targets Neural Mechanisms of Exercise: Effects on Gut Miccrobiota and Depression
CNS & Neurological Disorders - Drug Targets Interleukin-10
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry